122 related articles for article (PubMed ID: 8855814)
21. Mutational analysis of StAR gene in adrenal tumors.
Stigliano A; Caiola S; Siniscalchi E; Papini E; Crescenzi A; Monti S; Arnaldi G; Mantero F; Sciarra F; Toscano V
Int J Cancer; 2002 Jan; 97(3):357-60. PubMed ID: 11774288
[TBL] [Abstract][Full Text] [Related]
22. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
23. Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis.
Reincke M; Mora P; Beuschlein F; Arlt W; Chrousos GP; Allolio B
J Clin Endocrinol Metab; 1997 Sep; 82(9):3054-8. PubMed ID: 9284742
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland.
Ueberberg B; Unger N; Sheu SY; Walz MK; Schmid KW; Saeger W; Mann K; Petersenn S
Horm Metab Res; 2008 Mar; 40(3):181-8. PubMed ID: 18246525
[TBL] [Abstract][Full Text] [Related]
25. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
Beuschlein F; Schulze E; Mora P; Gensheimer HP; Maser-Gluth C; Allolio B; Reincke M
J Clin Endocrinol Metab; 1998 Jul; 83(7):2585-8. PubMed ID: 9661649
[TBL] [Abstract][Full Text] [Related]
26. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
Takahashi K; Totsune K; Saruta M; Fukuda T; Suzuki T; Hirose T; Imai Y; Sasano H; Murakami O
Peptides; 2006 Jan; 27(1):178-82. PubMed ID: 16095756
[TBL] [Abstract][Full Text] [Related]
27. Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors.
Sachse R; Shao XJ; Rico A; Finckh U; Rolfs A; Reincke M; Hensen J
Eur J Endocrinol; 1997 Sep; 137(3):262-6. PubMed ID: 9330590
[TBL] [Abstract][Full Text] [Related]
28. Content and biosynthesis of cortisol in aldosterone-producing adenomas.
Carballeira A; Fishman LM; Brown JW; Trujillo D
J Lab Clin Med; 1989 Aug; 114(2):120-8. PubMed ID: 2754301
[TBL] [Abstract][Full Text] [Related]
29. Utilization of molecular genetics in the differentiation between adrenal cortical adenomas and carcinomas.
Fogt F; Vargas MP; Zhuang Z; Merino MJ
Hum Pathol; 1998 May; 29(5):518-21. PubMed ID: 9596277
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors.
Barzon L; Chilosi M; Fallo F; Martignoni G; Montagna L; Palù G; Boscaro M
Eur J Endocrinol; 2001 Aug; 145(2):207-12. PubMed ID: 11454518
[TBL] [Abstract][Full Text] [Related]
31. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
32. Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.
Nakatsuka S; Hongyo T; Syaifudin M; Nomura T; Shingu N; Aozasa K
Jpn J Cancer Res; 2002 Mar; 93(3):267-74. PubMed ID: 11927008
[TBL] [Abstract][Full Text] [Related]
33. [How genomics upsets understanding of adrenal tumors?].
Assié G
Rev Prat; 2016 May; 66(5):539-545. PubMed ID: 30512579
[TBL] [Abstract][Full Text] [Related]
34. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
35. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas.
Liu J; Voutilainen R; Kahri AI; Heikkilä P
J Endocrinol; 1997 Feb; 152(2):175-81. PubMed ID: 9071974
[TBL] [Abstract][Full Text] [Related]
36. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
Slater EP; Diehl SM; Langer P; Samans B; Ramaswamy A; Zielke A; Bartsch DK
Eur J Endocrinol; 2006 Apr; 154(4):587-98. PubMed ID: 16556722
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
38. Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia.
Yashiro T; Hara H; Fulton NC; Obara T; Kaplan EL
World J Surg; 1994; 18(4):455-60; discussion 460-1. PubMed ID: 7725728
[TBL] [Abstract][Full Text] [Related]
39. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
[TBL] [Abstract][Full Text] [Related]
40. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
Baker SJ; Preisinger AC; Jessup JM; Paraskeva C; Markowitz S; Willson JK; Hamilton S; Vogelstein B
Cancer Res; 1990 Dec; 50(23):7717-22. PubMed ID: 2253215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
